» Authors » Yunwei Xia

Yunwei Xia

Explore the profile of Yunwei Xia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 128
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sokhi U, Xia Y, Sosa B, Turajane K, Nishtala S, Pannellini T, et al.
J Bone Miner Res . 2021 Dec; 37(3):577-594. PMID: 34897801
Staphyloccocus aureus is one of the major pathogens in orthopedic periprosthetic joint infection (PJI), a devastating complication of total joint arthroplasty that often results in chronic and persistent infections that...
2.
Dai Y, Li F, Jiao Y, Wang G, Zhan T, Xia Y, et al.
Cell Death Discov . 2021 Jun; 7(1):140. PMID: 34117210
Platinum drug treatment is one of the most predominant chemotherapeutic strategies for patients with gastric cancer (GC). However, the therapeutic effect is less than satisfactory, largely due to the acquired...
3.
Xia Y, Sokhi U, Bell R, Pannellini T, Turajane K, Niu Y, et al.
J Bone Miner Res . 2021 Jun; 36(9):1765-1780. PMID: 34076292
The importance of a local tissue immune response in healing injured tissues such as skin and lung is well established. Little is known about whether sterile wounds elicit lymph node...
4.
Li F, Xia Y, Wang G, Tang C, Zhan T, Shen J, et al.
Mol Genet Genomic Med . 2020 Jun; 8(8):e1295. PMID: 32490589
Background: Lynch syndrome (LS) is an autosomal-dominant disorder that increases the risk of many cancers. The genetic basis of LS is germline mutations in DNA mismatch repair genes. Methods: We...
5.
Qiu Y, Shan W, Yang Y, Jin M, Dai Y, Yang H, et al.
Cell Death Discov . 2019 Jul; 5:120. PMID: 31341646
Sorafenib resistance is one of the main obstacles to the treatment of advanced/recurrent hepatocellular carcinoma (HCC). Here, sorafenib-resistant HCC cells and xenografts in nude mice were used as experimental models....
6.
Qiu Y, Dai Y, Zhang C, Yang Y, Jin M, Shan W, et al.
J Exp Clin Cancer Res . 2018 Dec; 37(1):321. PMID: 30572915
Background: Multi-drug resistance (MDR) is one of the main obstacles for treatment of advanced/recurrent hepatocellular carcinoma (HCC). We have previously identified arsenic trioxide (ATO) as an effective metastasis/angiogenesis inhibitor in...
7.
Stuart T, ONeill K, Condon D, Sasson I, Sen P, Xia Y, et al.
Biol Reprod . 2018 Jan; 98(6):795-809. PMID: 29360948
Maternal obesity is associated with an increased risk of obesity and metabolic disease in offspring. Increasing evidence suggests that the placenta plays an active role in fetal programming. In this...
8.
Sutton E, Lob H, Song J, Xia Y, Butler S, Liu C, et al.
Am J Physiol Regul Integr Comp Physiol . 2017 Jan; 312(4):R485-R491. PMID: 28122721
Preeclampsia (PE) is a devastating disorder of pregnancy that classically presents with maternal hypertension and proteinuria after 20 wk of gestation. In addition to being a leading cause of maternal...